Simplicity Wealth’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.63M Buy
109,120
+64,440
+144% +$1.69M 0.09% 225
2026
Q1
$1.25M Buy
44,680
+4,601
+11% +$122K 0.07% 252
2025
Q4
$998K Sell
40,079
-7,589
-16% -$191K 0.06% 279
2025
Q3
$1.21M Sell
47,668
-12,320
-21% -$304K 0.07% 260
2025
Q2
$1.45M Sell
59,988
-14,255
-19% -$332K 0.06% 255
2025
Q1
$1.88M Buy
+74,243
New +$1.94M 0.15% 157
2024
Q4
Sell
-36,356
Closed -$1.05M 465
2024
Q3
$1.05M Sell
36,356
-101,417
-74% -$2.96M 0.1% 190
2024
Q2
$3.85M Sell
137,773
-3,974
-3% -$109K 0.09% 229
2024
Q1
$3.93M Buy
+141,747
New +$3.93M 0.09% 222

Other funds holding PFE

Simplicity Wealth's PFE Position: Q2 2026 in Review

Simplicity Wealth increased its Pfizer (PFE) stake by 144% in Q2 2026, buying an estimated $1.69M and bringing the position to 109,120 shares worth $2.63M. The position accounts for 0.09% of the portfolio, ranked #225.

Simplicity Wealth first reported a position in PFE in Q1 2024 and has held it in 9 quarters since. The position peaked at $3.93M in Q1 2024. 1,939 funds tracked by Wall St. Rank hold PFE as of Q2 2026.

  • Simplicity Wealth held 109,120 shares of Pfizer worth $2.63M as of Q2 2026.
  • Simplicity Wealth bought 64,440 Pfizer shares in Q2 2026, an estimated $1.69M.
  • Pfizer made up 0.09% of Simplicity Wealth's portfolio in Q2 2026, its #225 holding.
  • Simplicity Wealth first reported a position in Pfizer in Q1 2024 and has held it in 9 quarters since.
  • Simplicity Wealth's Pfizer position peaked at $3.93M in Q1 2024.
  • 1,939 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.

Based on Simplicity Wealth's 13F filing for Q2 2026, filed 6 Aug 2026.